Ksenia I. Zhukova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ksenia I. Zhukova has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Roman A. Litvinov
Volgograd State Medical University
6 shared publications - Umida M. Ibragimova
Volgograd State Medical University
6 shared publications - Svetlana A. Sorokina
Volgograd State Medical University
5 shared publications - Denis K. Deryagin
Volgograd State Medical University
4 shared publications - Nikita Valuisky
Volgograd State Medical University
4 shared publications - Alexander V. Borisov
Volgograd State Medical University
3 shared publications
Latest Publications
- 7 July 2026
- Published by Folium Publishing Company in Химико-фармацевтический журнал
- Vol. 60 (6) , 3-11
Оценка фармакокинетических свойств и лекарствоподобия in silico, синтез и антигликирующая активность новых N-гидроксибензоилпроизводных 5-метилтиазол-2-амина и 5-метилтиадиазол-2-амина
Разработан способ однореакторного многокомпонентного синтеза N-гидроксибензоилпроизводных 5-метилтиазол-2-амина и 5-метилтиадиазол-2-амина по реакции Шоттена – Баумана (метод Айнхорна) путем проведения последовательных реакций без выделения промежуточных продуктов: взаимодействием хлорангидридов гидроксибензойных кислот и их функциональных производных с соответствующим азолом при комнатной температуре в метиленхлориде, при pH 8 – 9. Структура полученных соединений подтверждена данными 1H и 13C ЯМР-спектроскопии. Рассмотрены способы прогноза фармакокинетических свойств и лекарствоподобия целевых производных in silico с применением различных программ, находящихся в открытом доступе. Выявлена значительная антигликирующая активность некоторых целевых соединений при испытании in vitro.
- 7 July 2026
- Published by Folium Publishing Company in Химико-фармацевтический журнал
- Vol. 60 (6) , 3-11
Оценка фармакокинетических свойств и лекарствоподобия in silico, синтез и антигликирующая активность новых N-гидроксибензоилпроизводных 5-метилтиазол-2-амина и 5-метилтиадиазол-2-амина
Разработан способ однореакторного многокомпонентного синтеза N-гидроксибензоилпроизводных 5-метилтиазол-2-амина и 5-метилтиадиазол-2-амина по реакции Шоттена – Баумана (метод Айнхорна) путем проведения последовательных реакций без выделения промежуточных продуктов: взаимодействием хлорангидридов гидроксибензойных кислот и их функциональных производных с соответствующим азолом при комнатной температуре в метиленхлориде, при pH 8 – 9. Структура полученных соединений подтверждена данными 1H и 13C ЯМР-спектроскопии. Рассмотрены способы прогноза фармакокинетических свойств и лекарствоподобия целевых производных in silico с применением различных программ, находящихся в открытом доступе. Выявлена значительная антигликирующая активность некоторых целевых соединений при испытании in vitro.
- Open Access
- 7 April 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (1) , 74-81
Antiglycating and antioxidant properties of selected natural acids and their derivatives
The study was aimed at determining the antiglycation and antioxidant (radical-scavenging) properties of a series of natural acids from the phenolic and triterpenic classes, in order to assess their suitability as scaffolds for the development of agents for the prevention and treatment of diseases in whose pathogenesis glycation and oxidative stress play a significant role, fibrotic diseases among them. The phenolic acids examined were the dextrorotatory and levorotatory enantiomers of usnic acid, perlatolic acid and usnetinic acid, and the triterpenic acid examined was ursolic acid. Gallic acid was used as a reference compound. Antiglycation activity was evaluated in a glucose-mediated albumin glycation model by quantifying the increase in advanced glycation end-products via their characteristic fluorescence (excitation 335–440 nm, emission 385–520 nm). Antioxidant properties were assessed using the ABTS assay. Perlatolic acid inhibited glycation by (31.8 ± 2.8) – (58.6 ± 1.4) % at 100 μM (depending on the selected excitation/emission wavelength pair) and exhibited radical-scavenging activity, reducing the optical density of the chromophore by (51.2 ± 0.8) % at 111 μM, thereby demonstrating the most favourable overall activity profile among the compounds investigated. However, despite this activity, perlatolic acid can be classified only as a moderately active antiglycator and antioxidant, as the reference compound gallic acid was substantially more potent. Usnetinic acid may likewise be regarded as a moderately active agent, whereas the remaining acids were less active. Both highlighted acids may serve as starting frameworks for further structural modification and the design of more active derivatives, potentially including the preparation of usnetinic and perlatolic acid gallates, in view of the high activity of gallic acid. Thus, we propose that these agents may be exploited as scaffolds for the design of new candidate molecules intended to modulate glycation- and oxidative stress-related mechanisms with potential relevance to fibrotic diseases.
- 7 April 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (1) , 74-81
Open AccessAntiglycating and antioxidant properties of selected natural acids and their derivatives
The study was aimed at determining the antiglycation and antioxidant (radical-scavenging) properties of a series of natural acids from the phenolic and triterpenic classes, in order to assess their suitability as scaffolds for the development of agents for the prevention and treatment of diseases in whose pathogenesis glycation and oxidative stress play a significant role, fibrotic diseases among them. The phenolic acids examined were the dextrorotatory and levorotatory enantiomers of usnic acid, perlatolic acid and usnetinic acid, and the triterpenic acid examined was ursolic acid. Gallic acid was used as a reference compound. Antiglycation activity was evaluated in a glucose-mediated albumin glycation model by quantifying the increase in advanced glycation end-products via their characteristic fluorescence (excitation 335–440 nm, emission 385–520 nm). Antioxidant properties were assessed using the ABTS assay. Perlatolic acid inhibited glycation by (31.8 ± 2.8) – (58.6 ± 1.4) % at 100 μM (depending on the selected excitation/emission wavelength pair) and exhibited radical-scavenging activity, reducing the optical density of the chromophore by (51.2 ± 0.8) % at 111 μM, thereby demonstrating the most favourable overall activity profile among the compounds investigated. However, despite this activity, perlatolic acid can be classified only as a moderately active antiglycator and antioxidant, as the reference compound gallic acid was substantially more potent. Usnetinic acid may likewise be regarded as a moderately active agent, whereas the remaining acids were less active. Both highlighted acids may serve as starting frameworks for further structural modification and the design of more active derivatives, potentially including the preparation of usnetinic and perlatolic acid gallates, in view of the high activity of gallic acid. Thus, we propose that these agents may be exploited as scaffolds for the design of new candidate molecules intended to modulate glycation- and oxidative stress-related mechanisms with potential relevance to fibrotic diseases.
- Open Access
- 7 April 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (1) , 50-58
Synthesis, characterization and biological properties of NiO nanoparticles
Introduction: Nickel oxide nanoparticles (NiO-NPs) are regarded as promising materials; however, the expansion of their applications requires detailed toxicological assessment in relevant experimental systems. In a range of models, nanostructured metal oxides have been shown to induce oxidative and inflammatory responses which, under certain conditions, may be involved in mechanisms of fibrotic remodelling. Macrophages act as early sensors of such exposures; therefore, analysing their functional response enables the characterisation of potential risks associated with NiO-NP exposure and provides a rationale for subsequent stages of safety evaluation. Research methodology: In this study, NiO-NPs were produced by a sol–gel method followed by thermal annealing at different temperatures. For further biological experiments, we selected the sample annealed at 450 °C, which exhibited the most reproducible nanoscale characteristics and was therefore considered optimal. Morphology and size parameters were assessed by electron microscopy, while phase composition and crystallite size were determined by X-ray diffraction, providing a comprehensive physicochemical characterisation of the tested material. Primary murine peritoneal macrophages were used as target cells. Cytotoxicity was evaluated using the MTT assay and morphocytological analysis, and the intensity of the cellular inflammatory response was assessed by measuring nitrite production with the Griess reagent. Results: The optimal NiO-NP sample was characterised by a predominantly nanoscale fraction and structural homogeneity, which supported its use in a cellular model for the assessment of biological effects. Exposure to NiO-NPs caused concentration-dependent impairment of macrophage viability. Marked cellular alterations were observed at high nanoparticle concentrations, whereas lower concentrations induced minimal signs of cellular damage or produced no detectable injury. In parallel, increased nitrite production was recorded, indicating activation of inflammatory mechanisms. Conclusion: Collectively, these data suggest that NiO-NPs may act as inducers of early cellular responses which, under unfavourable exposure conditions, could contribute to the development of a profibrotic tissue phenotype.
- 7 April 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (1) , 50-58
Open AccessSynthesis, characterization and biological properties of NiO nanoparticles
Introduction: Nickel oxide nanoparticles (NiO-NPs) are regarded as promising materials; however, the expansion of their applications requires detailed toxicological assessment in relevant experimental systems. In a range of models, nanostructured metal oxides have been shown to induce oxidative and inflammatory responses which, under certain conditions, may be involved in mechanisms of fibrotic remodelling. Macrophages act as early sensors of such exposures; therefore, analysing their functional response enables the characterisation of potential risks associated with NiO-NP exposure and provides a rationale for subsequent stages of safety evaluation. Research methodology: In this study, NiO-NPs were produced by a sol–gel method followed by thermal annealing at different temperatures. For further biological experiments, we selected the sample annealed at 450 °C, which exhibited the most reproducible nanoscale characteristics and was therefore considered optimal. Morphology and size parameters were assessed by electron microscopy, while phase composition and crystallite size were determined by X-ray diffraction, providing a comprehensive physicochemical characterisation of the tested material. Primary murine peritoneal macrophages were used as target cells. Cytotoxicity was evaluated using the MTT assay and morphocytological analysis, and the intensity of the cellular inflammatory response was assessed by measuring nitrite production with the Griess reagent. Results: The optimal NiO-NP sample was characterised by a predominantly nanoscale fraction and structural homogeneity, which supported its use in a cellular model for the assessment of biological effects. Exposure to NiO-NPs caused concentration-dependent impairment of macrophage viability. Marked cellular alterations were observed at high nanoparticle concentrations, whereas lower concentrations induced minimal signs of cellular damage or produced no detectable injury. In parallel, increased nitrite production was recorded, indicating activation of inflammatory mechanisms. Conclusion: Collectively, these data suggest that NiO-NPs may act as inducers of early cellular responses which, under unfavourable exposure conditions, could contribute to the development of a profibrotic tissue phenotype.
- Open Access
- 29 November 2025
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 13 (6) , 500-514
Synthesis and multimodal activity of 3a,6-epoxyisoindole-2(3H)-(carbox/thio/seleno)amides in models of glycation, oxidative stress, and inflammation: Toward the development of agents targeting the triggering mechanisms of fibrogenesis
The aim. Within a series of 3a,6-epoxyisoindole-2 (3H) -(carbox/thio/seleno)amides, we sought to identify a multimodal scaffold suitable for the further development of agents to prevent and treat fibrotic diseases by assessing of compound’s ability to mitigate glycation and oxidative stress, key triggers of fibrogenesis; to select a non-cytotoxic lead with a balanced combination of these two activities, and to preliminarily evaluate its anti-inflammatory potential. Materials and methods. Target 3a,6-epoxyisoindole-2( 3H )-(carbox/thio/seleno)amides were synthesised using the IMDAF approach. Antiglycation activity was evaluated in a bovine serum albumin-glucose model by registering advanced glycation end-product (AGE) fluorescence. Antioxidant properties were determined using the ABTS assay. Cytotoxicity and antiinflammatory effects were studied in peritoneal macrophages from adult wild-type white mice ( n = 4; body mass 30–35 g). Cytotoxicity was assessed by the MTT assay and lactate dehydrogenase (LDH) release, while anti-inflammatory effects were evaluated in a model of LPS-induced nitric oxide (NO) production. Results. The study delineates promising directions for modifying the epoxyisoindole scaffold for drug discovery and proposes a screening framework for agents targeting pathologies dependent on non-enzymatic damaging mechanisms (glycation, oxidation), including fibrotic diseases. Active molecules were identified among derivatives of hydrogenated 3a,6-epoxyisoindole. Compound 2.10 — 7a-chloro- N -(4-chlorophenyl)-1,6,7,7a-tetrahydro-3a,6-epoxyisoindole-2( 3H )carbothioamide — exhibited an optimal balance of antiglycation (at 100 μM, inhibition of glycation 40.1 ± 1.7%) and antioxidant activity (at 111 μM, reduction in ABTS•+ colour intensity 57.1 ± 1.1%) with low cytotoxicity (apparent from ≥ 250 μM). By contrast, compounds 2.16 – 2.19 (bearing an aroyl fragment) showed exceptionally high antioxidant activity (95.0–96.5% reduction in ABTS•+ colour intensity) without concordant antiglycation effects (inhibition not exceeding 15%). In the model used, anti-inflammatory activity of 2.10 was not detected. Conclusion. Compound 2.10 is a promising starting point for further structural optimisation toward agents acting on early pathogenetic events driven by non-enzymatic damaging triggers, including the prevention and treatment of fibrotic remodelling.
- 29 November 2025
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 13 (6) , 500-514
Open AccessSynthesis and multimodal activity of 3a,6-epoxyisoindole-2(3H)-(carbox/thio/seleno)amides in models of glycation, oxidative stress, and inflammation: Toward the development of agents targeting the triggering mechanisms of fibrogenesis
The aim. Within a series of 3a,6-epoxyisoindole-2 (3H) -(carbox/thio/seleno)amides, we sought to identify a multimodal scaffold suitable for the further development of agents to prevent and treat fibrotic diseases by assessing of compound’s ability to mitigate glycation and oxidative stress, key triggers of fibrogenesis; to select a non-cytotoxic lead with a balanced combination of these two activities, and to preliminarily evaluate its anti-inflammatory potential. Materials and methods. Target 3a,6-epoxyisoindole-2( 3H )-(carbox/thio/seleno)amides were synthesised using the IMDAF approach. Antiglycation activity was evaluated in a bovine serum albumin-glucose model by registering advanced glycation end-product (AGE) fluorescence. Antioxidant properties were determined using the ABTS assay. Cytotoxicity and antiinflammatory effects were studied in peritoneal macrophages from adult wild-type white mice ( n = 4; body mass 30–35 g). Cytotoxicity was assessed by the MTT assay and lactate dehydrogenase (LDH) release, while anti-inflammatory effects were evaluated in a model of LPS-induced nitric oxide (NO) production. Results. The study delineates promising directions for modifying the epoxyisoindole scaffold for drug discovery and proposes a screening framework for agents targeting pathologies dependent on non-enzymatic damaging mechanisms (glycation, oxidation), including fibrotic diseases. Active molecules were identified among derivatives of hydrogenated 3a,6-epoxyisoindole. Compound 2.10 — 7a-chloro- N -(4-chlorophenyl)-1,6,7,7a-tetrahydro-3a,6-epoxyisoindole-2( 3H )carbothioamide — exhibited an optimal balance of antiglycation (at 100 μM, inhibition of glycation 40.1 ± 1.7%) and antioxidant activity (at 111 μM, reduction in ABTS•+ colour intensity 57.1 ± 1.1%) with low cytotoxicity (apparent from ≥ 250 μM). By contrast, compounds 2.16 – 2.19 (bearing an aroyl fragment) showed exceptionally high antioxidant activity (95.0–96.5% reduction in ABTS•+ colour intensity) without concordant antiglycation effects (inhibition not exceeding 15%). In the model used, anti-inflammatory activity of 2.10 was not detected. Conclusion. Compound 2.10 is a promising starting point for further structural optimisation toward agents acting on early pathogenetic events driven by non-enzymatic damaging triggers, including the prevention and treatment of fibrotic remodelling.
- 18 October 2024
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 104 (4) , e14630
Directed Design, Screening and Antiglycation Activity for 3‐Substituted Thiazolium Derivatives, New Analogs of Alagebrium
Preliminary ab initio calculations led to the synthesis of novel substituted thiazolium salts, analogs of Alagebrium, which were further explored in vitro for their potential as inhibitors of the glycation reaction utilizing three distinct assays: inhibition of fluorescent AGEs formation, anticrosslinking, and deglycation. Despite the unidirectionality of the assays, distinct differences were observed in the mechanisms of interference and activity manifestation by the compounds. The gathered data permitted the formation of hypotheses about the molecular fragments of the studied antiglycators that are of utmost significance in each assay, thereby guiding future design endeavors. Potential mechanisms of actions are discussed therein. The compound 4‐meth‐yl‐3‐[2‐(4‐methylbiphenyl‐4‐yl)‐2‐oxoethyl] thiazolium bromide displayed high activity across all three assays, establishing it as a lead compound. The cytotoxicological properties of the compounds were evaluated using LDH and MTT assays. However, the lead compound exhibited cytotoxicity, indicating the need for additional investigations aimed at decreasing toxicity while maintaining activity. The targeted thiazolium salts were synthesized through an N‐alkylation reaction between the corresponding thiazoles and phenacyl bromides.
- 18 October 2024
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 104 (4) , e14630
Directed Design, Screening and Antiglycation Activity for 3‐Substituted Thiazolium Derivatives, New Analogs of Alagebrium
Preliminary ab initio calculations led to the synthesis of novel substituted thiazolium salts, analogs of Alagebrium, which were further explored in vitro for their potential as inhibitors of the glycation reaction utilizing three distinct assays: inhibition of fluorescent AGEs formation, anticrosslinking, and deglycation. Despite the unidirectionality of the assays, distinct differences were observed in the mechanisms of interference and activity manifestation by the compounds. The gathered data permitted the formation of hypotheses about the molecular fragments of the studied antiglycators that are of utmost significance in each assay, thereby guiding future design endeavors. Potential mechanisms of actions are discussed therein. The compound 4‐meth‐yl‐3‐[2‐(4‐methylbiphenyl‐4‐yl)‐2‐oxoethyl] thiazolium bromide displayed high activity across all three assays, establishing it as a lead compound. The cytotoxicological properties of the compounds were evaluated using LDH and MTT assays. However, the lead compound exhibited cytotoxicity, indicating the need for additional investigations aimed at decreasing toxicity while maintaining activity. The targeted thiazolium salts were synthesized through an N‐alkylation reaction between the corresponding thiazoles and phenacyl bromides.
- 27 December 2023
- Published by Springer Nature in Biogerontology
- Vol. 25 (3) , 507-528
Berberis vulgaris L. extract supplementation exerts regulatory effects on the lifespan and healthspan of Drosophila through its antioxidant activity depending on the sex
Worldwide the aging population continues to increase, so the concept of healthy longevity medicine has become increasingly significant in modern society. Berberis vulgaris L. fruits serve as a functional food supplement with a high concentration of bioactive compounds, which offer numerous health-promoting benefits. The goal of this study was to investigate the geroprotective effect of Berberis vulgaris L. extract. Here we show that extract of Berberis vulgaris L. can, depending on concentrate, increases lifespan up to 6%, promote healthspan (stress resistance up to 35%, locomotor activity up to 25%, integrity of the intestinal barrier up to 12%, metabolic rate up to 5%) of Drosophila melanogaster (in vitro) and exhibits antioxidant (using red blood cell tests) and antiglycation activity (using glycation of bovine serum albumin) (in vitro). In addition to this, the extract does not exhibit cytotoxic properties in vitro, unlike the well-known polyphenolic compound quercetin. qRT-PCR has revealed the involvement of metabolic, heat shock response and lipid metabolism genes in the observed effects.
- 27 December 2023
- Published by Springer Nature in Biogerontology
- Vol. 25 (3) , 507-528
Berberis vulgaris L. extract supplementation exerts regulatory effects on the lifespan and healthspan of Drosophila through its antioxidant activity depending on the sex
Worldwide the aging population continues to increase, so the concept of healthy longevity medicine has become increasingly significant in modern society. Berberis vulgaris L. fruits serve as a functional food supplement with a high concentration of bioactive compounds, which offer numerous health-promoting benefits. The goal of this study was to investigate the geroprotective effect of Berberis vulgaris L. extract. Here we show that extract of Berberis vulgaris L. can, depending on concentrate, increases lifespan up to 6%, promote healthspan (stress resistance up to 35%, locomotor activity up to 25%, integrity of the intestinal barrier up to 12%, metabolic rate up to 5%) of Drosophila melanogaster (in vitro) and exhibits antioxidant (using red blood cell tests) and antiglycation activity (using glycation of bovine serum albumin) (in vitro). In addition to this, the extract does not exhibit cytotoxic properties in vitro, unlike the well-known polyphenolic compound quercetin. qRT-PCR has revealed the involvement of metabolic, heat shock response and lipid metabolism genes in the observed effects.